Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries
- PMID: 37043751
- PMCID: PMC10234668
- DOI: 10.1093/eurpub/ckad055
Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries
Abstract
Background: This study aimed to investigate the status of cervical cancer screening (CCS) implementation in Europe by investigating national or regional policies towards broadening coverage of CCS amongst vulnerable subgroups of the population at high risk for CC.
Methods: A web-based survey was conducted between September 2021 and February 2022 with CCS programme managers and experts to identify and rank six population subgroups at high risk considered most vulnerable to CC and to map existing policies that addressed the coverage of CCS towards population sub-groups at risk.
Results: A total of 31 responses were received from experts covering 22 European countries. The results of this survey suggest that whilst many countries identify lower coverage of CCS amongst population subgroups at high risk of CC as a public health problem, few countries have developed dedicated policies towards broadening coverage among these subgroups. The six countries who reported having done so were concentrated in the Northern or Western European regions, suggesting the existence of geographical disparities within the continent. A key challenge in this respect is the difficulty to categorize subgroups of the target population; many individuals are burdened by intersectionality thereby resting in multiple categories, which may hinder the effectiveness of interventions targeted to reach specific subgroups.
Conclusion: A greater clarity on the conceptualization of vulnerability can help countries to develop and subsequently implement strategies to increase coverage to subgroups of the target population currently underserved with regards to CCS.
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association.
Similar articles
-
Development and pilot implementation of a novel protocol to assess capacity and readiness of health systems to adopt HPV detection-based cervical cancer screening in Europe.Health Res Policy Syst. 2024 Aug 12;22(1):102. doi: 10.1186/s12961-024-01190-y. Health Res Policy Syst. 2024. PMID: 39135116 Free PMC article.
-
Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.BMC Cancer. 2023 Dec 8;23(1):1216. doi: 10.1186/s12885-023-11683-8. BMC Cancer. 2023. PMID: 38066496 Free PMC article.
-
Cervical cancer screening policies and coverage in Europe.Eur J Cancer. 2009 Oct;45(15):2649-58. doi: 10.1016/j.ejca.2009.07.020. Epub 2009 Aug 19. Eur J Cancer. 2009. PMID: 19699081
-
Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies.BMC Public Health. 2022 Aug 10;22(1):1530. doi: 10.1186/s12889-022-13827-0. BMC Public Health. 2022. PMID: 35948944 Free PMC article.
-
Factors associated with cervical cancer screening participation among migrant women in Europe: a scoping review.Int J Equity Health. 2020 Sep 11;19(1):160. doi: 10.1186/s12939-020-01275-4. Int J Equity Health. 2020. PMID: 32917224 Free PMC article.
Cited by
-
HPV-associated cancers among people living with HIV: nationwide population-based retrospective cohort study 2004-21 in Estonia.Eur J Public Health. 2024 Dec 1;34(6):1199-1204. doi: 10.1093/eurpub/ckae152. Eur J Public Health. 2024. PMID: 39378418 Free PMC article.
-
How can cervical screening meet the needs of vulnerable women? A qualitative comparative study with stakeholder perspectives from seven European countries.BMJ Open. 2025 Jan 25;15(1):e090631. doi: 10.1136/bmjopen-2024-090631. BMJ Open. 2025. PMID: 39863407 Free PMC article.
-
Overcoming barriers to cervical screening attendance among underrepresented populations in Europe.Lancet Reg Health Eur. 2024 May 16;42:100932. doi: 10.1016/j.lanepe.2024.100932. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 38800109 Free PMC article. No abstract available.
-
What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries.BMJ Open. 2024 May 17;14(5):e079921. doi: 10.1136/bmjopen-2023-079921. BMJ Open. 2024. PMID: 38760040 Free PMC article.
-
Barriers and facilitators to cervical cancer screening among under- and neverscreened women in Flanders, Belgium - a qualitative study on community and healthcare providers' perspectives.BMC Public Health. 2024 Oct 18;24(1):2870. doi: 10.1186/s12889-024-20166-9. BMC Public Health. 2024. PMID: 39425098 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49. - PubMed
-
- Ferlay J, Laversanne M, Ervik M, et al.Global Cancer Observatory: Cancer Tomorrow. Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer; 2020.
-
- World Health Organization. Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem and Its Associated Goals and Targets for the Period 2020 – 2030, Vol. 2, Geneva: United Nations General Assembly, 2021; 1–3.
-
- European Commission. Communication from the Commission to the European Parliament and the Council. Europe’s Beating Cancer Plan. 2021. Available at: https://health.ec.europa.eu/system/files/2022-02/eu_cancer-plan_en_0.pdf (28 November 2022, date last accessed).
-
- Cohen PA, Jhingran A, Oaknin A, Denny L.. Cervical cancer. Lancet 2019;393:169–82. - PubMed